Grimes & Company’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Buy |
58,436
+48,436
| +484% | +$128K | ﹤0.01% | 404 |
|
|
2025
Q1 | $30.1K | Hold |
10,000
| – | – | ﹤0.01% | 366 |
|
|
2024
Q4 | $25.6K | Hold |
10,000
| – | – | ﹤0.01% | 379 |
|
|
2024
Q3 | $37.2K | Hold |
10,000
| – | – | ﹤0.01% | 359 |
|
|
2024
Q2 | $63.2K | Hold |
10,000
| – | – | ﹤0.01% | 340 |
|
|
2024
Q1 | $53.7K | Hold |
10,000
| – | – | ﹤0.01% | 335 |
|
|
2023
Q4 | $50.2K | Hold |
10,000
| – | – | ﹤0.01% | 322 |
|
|
2023
Q3 | $16.9K | Hold |
10,000
| – | – | ﹤0.01% | 304 |
|
|
2023
Q2 | $27.8K | Buy |
+10,000
| New | +$27.8K | ﹤0.01% | 306 |
|